SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019638
Filing Date
2018-08-07
Accepted
2018-08-07 07:01:52
Documents
94
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20180630.htm 10-Q 2159406
2 EX-31.1 reph-ex311_9.htm EX-31.1 17438
3 EX-31.2 reph-ex312_8.htm EX-31.2 17284
4 EX-32.1 reph-ex321_6.htm EX-32.1 8138
  Complete submission text file 0001564590-18-019638.txt   10223368

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20180630.xml EX-101.INS 2555325
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20180630.xsd EX-101.SCH 71101
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20180630_cal.xml EX-101.CAL 63155
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20180630_def.xml EX-101.DEF 276842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20180630_lab.xml EX-101.LAB 551992
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20180630_pre.xml EX-101.PRE 462837
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 18996248
SIC: 2834 Pharmaceutical Preparations